Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021

Rhea-AI Summary

Eagle Pharmaceuticals (NASDAQ: EGRX) announced that CEO Scott Tarriff and CFO Brian Cahill will present at the Piper Sandler 33rd Annual Healthcare Conference on November 22, 2021, at 10:00 AM ET. Attendees can access the on-demand webcast via the company's website for 90 days post-event. Additionally, Eagle will hold one-on-one meetings on December 1, 2021, which must be requested through Piper Sandler. Eagle focuses on developing innovative medicines and has products including RYANODEX®, BENDEKA®, and BELRAPZO®.

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present virtually at the Piper Sandler 33^rd Annual Healthcare Conference 2021 as follows:

Date:		Monday, November 22, 2021
Time/On Demand:		10:00AM ET
Webcast:		https://pipersandler.zoom.us/rec/play/gKb-8Uf5FTyDI-TguX2M-ziZvOHQuT9LOFMBE7BTLwbNzRNQz-5dpn0wd3T7bdN8bc14RITsJSMvcBEZ.2zBLSfAaut02uDfV

The webcast of the previously recorded presentation will be accessible on demand and archived for 90 days thereafter, via the Company’s website at www.eagleus.com, under the Investors section.

Eagle will be participating in 1x1 meetings on December 1. Meetings can be requested exclusively via Piper Sandler.

About Eagle Pharmaceuticals, Inc.

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX^®, BENDEKA^®, BELRAPZO^®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211122005873/en/

Investor Relations for Eagle Pharmaceuticals, Inc.:

Lisa M. Wilson

In-Site Communications, Inc.

T: 212-452-2793

E: lwilson@insitecony.com

Source: Eagle Pharmaceuticals, Inc.

FAQ

When will Eagle Pharmaceuticals present at the Piper Sandler Healthcare Conference?

Eagle Pharmaceuticals will present on November 22, 2021, at 10:00 AM ET.

Where can I watch Eagle Pharmaceuticals' presentation?

The webcast can be accessed on-demand through Eagle Pharmaceuticals' website for 90 days after the presentation.

When is the one-on-one meeting with Eagle Pharmaceuticals?

Eagle Pharmaceuticals will participate in one-on-one meetings on December 1, 2021.

What products does Eagle Pharmaceuticals offer?

Eagle Pharmaceuticals offers products including RYANODEX®, BENDEKA®, and BELRAPZO®.

What is Eagle Pharmaceuticals' stock symbol?

Eagle Pharmaceuticals' stock symbol is EGRX.